Search

everythinglearnresearchcommunity

for

Search:↓

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Thymus-derived Tregs, not peripherally-derived Tregs, primarily regulate type 1 diabetes in the NOD mouse model.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

Steven Kossard classified lymphocyte-related hair loss into four patterns, each linked to different types of baldness.

Over half of the diabetes patients had skin issues, with fungal infections being most common.

The nail matrix has a reduced immune response, protecting it from autoimmunity.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

Targeted immune modulation can help achieve stable remission in alopecia areata.

Skin cells control immune cell placement, helping the skin respond better to challenges.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

γδTregs can protect hair follicles from alopecia areata and may help regrow hair.

Type 2 immunity helps control mite growth in hair follicles, preventing damage.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

TLR3 signaling enhances the immunosuppressive properties of human periodontal ligament stem cells.

Two new IRAK4-inhibitors effectively reduced skin inflammation and immune response markers in healthy volunteers.

Certain immune system proteins are important for skin healing but can cause problems if there are too many of them.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

IL-17 and certain immune cells are linked to more severe alopecia areata.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

Improving nerve and immune interactions may help heal chronic wounds.

Age-related immune changes significantly affect disease development in other systems.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Activin increases skin tumor formation, skin Tregs help hair growth, lymph-node removal doesn't improve melanoma survival, cells can revert to stem cells in wound healing, and skin bacteria produce peptides that may treat infections.

TNF-alpha inhibitors can cause various immune-related skin issues.